Alergosan 2 ml 1%. 10 ampoules

COMPOSITION
In one ampoule 2.ml contain:
Active substance: Choropyramine hydrochloride 20 mg '
Excipients: Hydrochloric acid 1 mol / 1 and pH 5.5-6.5, water for injections.
 
PHARMACEUTICAL FORM AND Pharmaco-therapeutic group
Alergosan form of injection is hypoallergenic product.
 
INDICATIONS
In what cases can be applied Alergosan? Acute allergic reactions associated with treatment of hives (food, medicines, helminths, etc.). And bites nasekomi.Pri allergic reactions of the general type (anaphylaxis, serum sickness, edema Quincke) is used as component of complex therapy.
 
CONTRAINDICATIONS
In which cases should not apply the product?
Shall not apply in case of hypersensitivity to constituents, glaucoma (increased intraocular pressure) .adenom (tumor) of the prostate gland, acute peptic ulcer, pyloroduodenal stenosis (narrowing of the lower part of the stomach or duodenum), pregnancy and lactation.
 
PRECAUTIONS FOR USE
When Alergosan may be used with caution?
Use with caution in patients with overactive thyroid gland, heart disease, and asthma in adults over 60 years of caution is needed, as it can cause dizziness, drowsiness and lowering blood pressure in children and can lead to excitatory reactions. The product should not be taken with alcohol and sedatives due to strengthen their action.
 
SPECIAL WARNING
As there is little clear evidence of the safety of the product during pregnancy and lactation is not recommended its prilozhenie.Poradi pronounced its sedative product should be administered with caution to drivers of vehicles and handling mashini.chch
 
DRUG INTERACTIONS
What other drugs affect the action of Alergosan?
Not recommended for use concomitantly with Alergozan cholinolytics (atropine, Buscolysin etc.), As they may strengthen the effects im.Produktat should not be administered concomitantly with monoamine oxidase inhibitors (moclobemide and coatings, etc.). Before starting treatment with Alergozan is necessary to have an interval of two weeks after stopping inhibitors monoaminooksidazata.Vsichki drugs that have a suppressive effect on the central nervous system (painkillers, antipsychotics and anti) reinforce the sedative effect of Alergozan.Tryabva tell your doctor in case of any concomitant therapy with other drugs in order to avoid any possible interaction between them.
 
METHOD AND DOSAGE
The dosage and duration of treatment is determined by the doctor depending on the severity of the disease and tolerability produkta.Prilaga be intramuscularly or intravenously in 1 ampoule once to twice dnevno.Pri transfusions can be administered prophylactically in 1 vial in 500 ml of blood in the early blood transfusion.
 
SIDE EFFECTS
What side effects may occur in the application of Alergosan?
Nervous system: drowsiness, fatigue, dizziness, fatigue, glovobolie.
Digestive system: dry mouth, nausea, vomiting, constipation.
Excretory system: urinary retention and difficulty in urination.
Skin and mucous membranes: allergy, sensitivity to light.
Other: visual disturbances - double vision and increased intraocular pressure; karina blood Reduction of the number of. white blood cells, red blood cells, platelets her; muscle - twitching.
For all adverse reactions, including effects not listed in this leaflet, the patient should be immediately reported to your doctor.
 
OVERDOSE
What to do if Alergozan administered in very high doses (intentional overdose or wrong)?
Overdose product symptoms occur mainly on the central nervous system - inhibition or stimulation. In infants and young children dominate stimulating effect, which is expressed with the following symptoms: incoordination, agitation, hallucinations, garchove.Pri adults more frequently monitor the effects of depression: dizziness, drowsiness, depressed reflexes and active vnimannie, Treatment of overdose consists in the application of water-salt solutions, respiratory and cardiovascular support and resources affecting the symptoms of overdose.In case of overdose seek immediate medical care;
 
Storage Instructions
In the original. packaging protected from light at a temperature below 25 ° S.Da Keep out of reach of children!
SHELF LIFE
Da non-use after the expiry date!
 
DATA PACKAGE
The product was filled into colorless ampules of 2 ml. Ten vials were placed in a blister of solid PVC foil. One or ten blister placed in a cardboard box together with a package leaflet.